Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Philip Morris International Inc. (PM) A Good Stock To Buy?

Page 1 of 2

It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. The Standard and Poor’s 500 Index returned 5.2% over the 12-month period ending October 30, while more than 51% of the constituents of the index underperformed the benchmark. Hence, a random stock picking process will most likely lead to disappointment. At the same time, the 30 most favored S&P 500 stocks by the hedge funds monitored by Insider Monkey (as of September 2014) generated a return of 9.5% over the same time span, with 63% of these stocks outperforming the benchmark. Of course, hedge funds do make wrong bets on some occasions and these get disproportionately publicized in financial media, but piggybacking their moves can beat the broader market on average. That’s why we are going to go over recent hedge fund activity in Philip Morris International Inc. (NYSE:PM).

Is Philip Morris International worth your attention right now? Investors who are in the know are taking a bullish view. The number of long hedge fund positions inched up by 1 in recent months. PM was in 42 hedge funds’ portfolios at the end of September. There were 41 hedge funds in our database with PM holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Unilever N.V. (ADR) (NYSE:UN), Unilever plc (ADR) (NYSE:UL), and UnitedHealth Group Inc. (NYSE:UNH) to gather more data points.

Follow Philip Morris International Inc. (NYSE:PM)
Trade (NYSE:PM) Now!

Today there are numerous formulas stock traders put to use to assess stocks. A couple of the most underrated formulas are hedge fund and insider trading activity. Our researchers have shown that, historically, those who follow the best picks of the top money managers can outpace their index-focused peers by a superb amount (see the details here).

Now, let’s go over the fresh action encompassing Philip Morris International Inc. (NYSE:PM).

How have hedgies been trading Philip Morris International Inc. (NYSE:PM)?

At the end of the third quarter, a total of 42 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 2% from one quarter earlier. With the smart money’s capital changing hands, there exists a select group of noteworthy hedge fund managers who were boosting their holdings meaningfully (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Cedar Rock Capital, managed by Andy Brown, holds the number one position in Philip Morris International Inc. (NYSE:PM). Cedar Rock Capital has a $987.4 million position in the stock, comprising 25.7% of its 13F portfolio. On Cedar Rock Capital’s heels is Tom Russo’s Gardner Russo & Gardner with a $831.4 million position; the fund has 7.5% of its 13F portfolio invested in the stock. Other professional money managers with similar optimism include Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, Phill Gross and Robert Atchinson’s Adage Capital Management and Cliff Asness’ AQR Capital Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!